Latest Clinical research Podcast Episodes
New Frontiers in MASH and Chronic Liver Diseases with Aligos CEO Dr. Lawrence Blatt
Xtalks Life Science Podcast - July 03, 2024 09:00 - 34 minutes - VideoIn this episode, Ayesha spoke with Lawrence Blatt, PhD, MBA, Chairman and CEO of Aligos Therapeutics, a company developing targeted therapies for liver diseases like MASH (metabolic dysfunction-associated steatohepatitis) and viral diseases to address important unmet medical needs. Prior to co-...
FNIH’s Dr. Travaglia and ALS Patient Advocate Dr. Sethi Discuss New ALS Program
Xtalks Life Science Podcast - June 26, 2024 09:00 - 30 minutes - VideoIn this episode, Ayesha spoke with Alessio Travaglia, PhD, Director Neuroscience at the Foundation for the National Institutes of Health (FNIH) who also manages FNIH’s new Accelerating Medicines Partnership in Amyotrophic Lateral Sclerosis (AMP ALS) program, and Nadia Sethi, DDS, an ALS patient ...
Behind the Budget: Exploring Hidden Costs in Clinical Trials
SCRS Talks - June 24, 2024 23:00 - 18 minutesHidden costs remain a persistent challenge for clinical research sites. With over two decades of experience, SCRS Project Manager Mike Pierre discusses the evolution of hidden costs, the ongoing efforts by SCRS to address them, and the launch of a Hidden Costs workshop. Whether you're a site ...
Why Clinical Researchers Are Flocking to MedSpas
DarshanTalks Podcast - June 24, 2024 13:00 - 32 minutes ★★★★★ - 1 ratingIn today’s episode, our guest is Andrew Stein, a partner in the healthcare department at Stevens and Lee . Darshan and Andrew discuss MedSpas. MedSpas combine beauty treatments with medical procedures, blurring the lines between pampering and healthcare. To navigate this complexity, they talk a...
The Road Ahead for Former ALS Hopeful Relyvrio ft. Amylyx's Joshua Cohen and Justin Klee
Xtalks Life Science Podcast - June 19, 2024 13:47 - 41 minutesIn this episode, Ayesha spoke with Joshua Cohen and Justin Klee, co-CEOs and co-founders of Amylyx Pharmaceuticals, a company developing therapeutics for neurodegenerative diseases like amyotrophic lateral sclerosis (ALS). Josh and Justin co-founded Amylyx Pharmaceuticals in 2013. Josh co-inven...
Legal Minute: Why You Should Never Trust a Celebrity with Your Health
DarshanTalks Podcast - June 18, 2024 13:00 - 51 seconds ★★★★★ - 1 ratingDarshan explains why you shouldn’t Trust Celebrities When Choosing Your Drugs! Hidden Agendas: They're paid to promote, not give unbiased advice. Not Medical Experts: Trust your doctor's knowledge, not a celebrity's opinion. Oversimplified Info: 30-second ads can't tell the whole story. Not Per...
Essential tips for pharmacy shutdowns
DarshanTalks Podcast - June 16, 2024 13:00 - 2 minutes ★★★★★ - 1 ratingRecent pharmacy walkouts and closures at major chains highlight a critical issue: staffing shortages. Independent pharmacies are also at risk. Here are 5 tips for pharmacy owners and managers to prepare for potential temporary closures: Cross-Train Staff: Train front-end staff on basic pharma...
Insights into Precision Dosing with Dr. Howard McLeod and Dr. Sharmeen Roy
Xtalks Life Science Podcast - June 12, 2024 09:00 - 38 minutesIn this episode, Ayesha spoke with Howard McLeod, PharmD, Director of the Center for Precision Medicine and Functional Genomics, Professor of Pharmacy and Medicine at Utah Tech University and Precision Medicine Advisor at the Geriatric Oncology Consortium; and Sharmeen Roy, PharmD, Chief Strateg...
Meet SCRS Global Impact Partner: Accelerate Recruitment Services
SCRS Talks - June 11, 2024 16:00 - 14 minutesCarlos Bussey, CEO of Accelerate Recruitment Services, dives deep into the groundbreaking innovations his company is bringing to the table and their role in the SCRS Global Impact Partner program. Hear the journey of this forward-thinking organization working to support clinical research sites a...
Legal Minute: 5 Surprising Benefits of Ozempic!
DarshanTalks Podcast - June 11, 2024 13:00 - 45 seconds ★★★★★ - 1 ratingWe dive deep into 5 uses of Ozempic, a drug known for managing diabetes, but with surprising potential beyond! Here are 5 intriguing uses you might not have heard of: Liver Support: Early research suggests Ozempic could benefit liver health, but more studies are needed. Weight Loss Weapon: Oze...
Who Owns AI Generated Content in Pharma?
DarshanTalks Podcast - June 08, 2024 20:00 - 7 minutes ★★★★★ - 1 ratingIn today's episode, we discuss AI-generated content in the pharmaceutical industry. AI has revolutionized content creation, but it's not without its legal and ethical dilemmas. Take, for instance, the New York Times' lawsuit against OpenAI, highlighting the contentious issue of data ownership. A...
Legal Minute: Why does my drug cost so much?
DarshanTalks Podcast - June 07, 2024 14:00 - 48 seconds ★★★★★ - 1 ratingIn today’s short, Darshan discusses why drugs cost so much. It takes around 10 to 15 years and roughly $2.3 billion to bring a drug to market. That means a drug company spends between $420,000 and $630,000 daily during this process. Imagine going to a casino every day, betting that much money wi...
AI for Promotions in FDA-Regulated Industries
DarshanTalks Podcast - June 06, 2024 16:00 - 57 seconds ★★★★★ - 1 ratingJoin Darshan Kulkarni, a Food and Drug attorney, as he explores the dynamic intersection of artificial intelligence, drug and device promotion, and the law. In this podcast series, we'll dive deep into AI's role in promotional and non-promotional communications within the pharmaceutical and...
Legal Minute: Billion-Dollar Speaker Scheme!
DarshanTalks Podcast - June 05, 2024 13:00 - 44 seconds ★★★★★ - 1 ratingSpeaker programs are events sponsored by drug and device companies where a physician or other healthcare professional (HCP) delivers a speech or presentation to fellow HCPs regarding a specific drug, device product, or disease state on behalf of the sponsoring company. Typically, the company com...
Targeting AML with a New Generation of T-Cell Therapies, ft. Brian Atwood, Chairman and CEO of CERo Therapeutics
Xtalks Life Science Podcast - June 05, 2024 09:00 - 29 minutesIn this episode, Ayesha spoke with Brian Atwood, Chairman and CEO of CERo Therapeutics, a company pioneering a new generation of autologous T-cell-based therapies for both hematologic and solid tumor cancers. Prior to joining CERo, Brian Atwood served as Chairman of the board of directors of P...
Off-Label Risks: Compliance Matters Now More Than Ever
DarshanTalks Podcast - June 03, 2024 13:00 - 24 minutes ★★★★★ - 1 ratingWe shed light on the complexities surrounding off-label promotion and reimbursement in the pharmaceutical industry. We discuss the following: What does off-label mean from a reimbursement standpoint? Lessons from the US v. Eli Lilly 2009 case How do recent court decisions impact off-label ...
6 Must-Knows Before Buying a Drug or Device Company
DarshanTalks Podcast - May 30, 2024 14:00 - 1 minute ★★★★★ - 1 ratingBuying a Drug or Device Company? 6 Compliance Must-Knows Thinking of acquiring a drug or device company? Buckle up! This deal requires serious compliance considerations. Here's a quick rundown: The DOJ offers a 6-month "safe harbor" for confessing past compliance issues. Use it! The DOJ demands...
Exploring Next-Gen Antivirals ft. Sam Lee, PhD, Co-CEO & President, Cocrystal Pharma
Xtalks Life Science Podcast - May 29, 2024 09:00 - 24 minutesIn this episode, Ayesha spoke with Sam Lee, PhD, Co-Chief Executive Officer and President of Cocrystal Pharma, a company developing novel antiviral therapeutics against COVID-19 and other coronaviruses, influenza viruses and noroviruses. Cocrystal Pharma leverages a unique structure-based drug ...
Episode 29: The Meghan Malley Wellness Program
Evidence To Excellence: News In Neuroplasticity and Rehab - May 28, 2024 23:00 - 48 minutesHost Polly Swingle is joined by Dr. Kayla Diebold, PT, DPT, Heath Stilwell, NSCA Certified Personal Trainer, and Andy Kronk, participant in The Meghan Malley Wellness Program at The Recovery Project. Listen in to learn about the re-naming of the wellness programs offered at The Recovery Project ...
Legal Minute: Are there chemo drug shortages?
DarshanTalks Podcast - May 28, 2024 13:00 - 50 seconds ★★★★★ - 1 ratingWe discuss how recent shortages of chemotherapy drugs like cisplatin and carboplatin have caused delays and changes in treatment plans for some cancer patients. While the situation is improving, shortages still exist for some drugs. Staying informed is crucial, and the FDA is actively tracking d...
Are there chemo drug shortages?
DarshanTalks Podcast - May 28, 2024 13:00 - 50 seconds ★★★★★ - 1 ratingWe discuss how recent shortages of chemotherapy drugs like cisplatin and carboplatin have caused delays and changes in treatment plans for some cancer patients. While the situation is improving, shortages still exist for some drugs. Staying informed is crucial, and the FDA is actively tracking d...
Transforming Clinical Trials with Patient-Finding Technology
SCRS Talks - May 27, 2024 12:00 - 17 minutesGary White, the Senior Director with EMEA Strategic Site Solutions at IQVIA explores the evolution of patient-finding technology. In this episode, discover how IQVIA's digital solutions are reshaping traditional data collection methods, unlocking new possibilities for research sites and patients...
Legal Minute: Don’t Ignore State Registrations
DarshanTalks Podcast - May 24, 2024 19:00 - 35 seconds ★★★★★ - 1 ratingWe discuss how failure to register with the appropriate state boards of Pharmacy as a drug or device manufacturer can lead to severe consequences. These consequences include 1. Hefty fines, revoked licenses, and even legal charges, potentially ruining your business. 2. Additionally, non-compli...
Gene Editing Innovations with Programmable Gene Insertion (PGI) Technology ft. Dr. John Finn, Tome Biosciences
Xtalks Life Science Podcast - May 22, 2024 09:00 - 33 minutesIn this episode, Ayesha spoke with John Finn, PhD, Chief Scientific Officer at Tome Biosciences, a company developing programmable gene insertion (PGI) technology. PGI is a cutting-edge gene editing technology that allows for the insertion of large sequences of DNA with site-specific precision....
Legal Minute: 6 Crucial Mistakes in Informed Consent
DarshanTalks Podcast - May 20, 2024 13:00 - 59 seconds ★★★★★ - 1 ratingWe discuss six critical errors in the informed consent process: 1. Exclusion of Principal Investigator: PI was not allowed to engage in the informed consent process. 2. Lack of Detailed Discussion: Staff members did not take the time to thoroughly discuss the study's potential benefits and risk...
Meet SCRS Global Impact Partner: Science 37
SCRS Talks - May 20, 2024 12:00 - 16 minutesMeet SCRS Global Impact Partner, Science 37! Dr. Debra Weinstein, Vice President of Internal Medicine, discusses Science 37's dedication to site success and collaboration. Hear insights into Science 37's initiatives, including their referral network and recruitment strategies, as well as their g...
Legal Minute: What is informed consent in clinical trials?
DarshanTalks Podcast - May 16, 2024 13:00 - 46 seconds ★★★★★ - 1 ratingInformed consent is a crucial aspect of clinical trials, ensuring that prospective subjects understand the benefits, risks, and potential harms of participating in a study. This process involves full disclosure of information, allowing subjects to ask questions and address concerns with a knowl...
What is informed consent in clinical trials?
DarshanTalks Podcast - May 16, 2024 13:00 - 46 seconds ★★★★★ - 1 ratingInformed consent is a crucial aspect of clinical trials, ensuring that prospective subjects understand the benefits, risks, and potential harms of participating in a study. This process involves full disclosure of information, allowing subjects to ask questions and address concerns with a knowl...
New Frontiers in Epilepsy and Seizure Treatments ft. Dr. Jeremy Levin and Meg Alexander, Ovid Therapeutics
Xtalks Life Science Podcast - May 15, 2024 09:00 - 47 minutesIn this episode, Ayesha spoke with Jeremy Levin, D. Phil, MB BChir, CEO and Chairman of Ovid Therapeutics Inc., and Meg Alexander, Chief Strategy Officer at Ovid. Ovid Therapeutics is a biopharmaceutical company focused on the development of medicines for epilepsies and seizure-related neurolog...
Stop Risky Ads: Class Actions Could Cost You
DarshanTalks Podcast - May 13, 2024 13:00 - 22 minutes ★★★★★ - 1 ratingIn this podcast, we discuss the following: Recent updates from the courts in class action lawsuits. Difference between equity and law. Demerging or diverging equity and law. Dictionaries used by courts to interpret contracts. Update on Johnson and Johnson baby powder case (Suing plaint...
Related Clinical research Topics
- Clinical trials 4
- Medical devices 3
- Science 2
- Research 2
- Medicine 2
- Health care 2
- Fda 2
- Healthcare 2
- Medical research 2
- Pharma 2
- Pharmaceuticals 2